GSK’S Market Share & Position PDF

Acknowledgement
All praises goes to all mighty Allah, the most gracious and the most merciful without whose blessing we could
not have completed this report.
The accomplishment and completion of this report would not have been viable without the contribution of some
accommodative people, who gave their valuable time from their busy schedule to guide us in doing our
project work.
We would like to extend our heartiest gratitude to all those who directly or indirectly contributed to the
competition of the report. At the beginning, we would like to convey our gratitude and appreciation to our
supervisor at GSK, Bangladesh Mr. Syed Ali Sajjad, Training Manager for his intimate and tremendous
support and cooperation.
We would also like to express our gratitude to Mr. A.K.M. Firoz Alam, Director HR at GSK, Bangladesh for
giving us the opportunity to experience real life business environment.
we would also like to thank to our academic supervisor Mr. Masnoon Salehin, Lecturer in Management of Dhaka
University Business School for providing valuable guidelines in preparing the report.

Executive Summary
GSK started its journey in Bangladesh on the year 1949 as an importer of its own products and its importing
activities used to hold in Chittagong but eventually it emerged its roles to manufacturing sector also and
established factory in Chittagong. So, GSK is operating in Bangladesh for 63 years and it’s really providing
excellent service in Consumer Healthcare and Pharmaceutical sector. GSK has a strong HR department
which is working in line with the strategies of the organization and working with the aim of attaining the
mission and vision of the company. GSK has mainly three divisions in HR department and these are - HR
development, HR services and administration. Under the HR department performance appraisal system takes
place. A survey is conducted at corporate office of GSK to evaluate the appraisal system. The whole report
is divided into six parts. First part comprises of introduction part which includes- objectives, methodology,
scope, limitations of the study, second part comprises of organizational overview which includes GSK
worldwide to GSK Bangladesh. Moreover, third part comprises a briefing on performance appraisal system;
its history, techniques, perceptual errors; fourth part comprises of performance appraisal system conducted
at GSK Bangladesh and fifth part includes findings and analysis of the research conducted through my
internship period and last part comprises conclusion and recommendation and its effective implementation.

Table of Contents
Contents Page no.
Letter of transmittal -
Acknowledgement -
Executive summary -
Chapter-1(Introduction)
1.1 Introduction 1-2
1.2 Objectives of The Study 2-3
1.3 Scope of The study 3
1.4 Methodology 3-5
1.5 Limitations 5
Chapter-2 ( Organizational Overview)
2.1 GSK- At a Glance 6
2.2 GSK in time 6
2.3 History of GSK 6-7
2.4 GSK- Mission, Strategic
Intent & Spirit
8
2.5 Global Operation 8-9
2.6 GSK Bangladesh Limited 9-11
2.7 Organizational structure of Company 12-14
2.8 Functional Department of
GSK Bangladesh Ltd.
14-16
2.9 Product line of GSK, Bangladesh, Limited 17
2.10 GSK’S Market Share & Position 18
2.11 SWOT Analysis 19-20
Chapter-3(Overview of Performance
Appraisal System)
3.1 History of Performance Appraisal 21
3.2 Objectives of Performance Appraisal
Method
21-22
3.3 Performance Appraisal Techniques 22
3.4 Brief Discussion of some performance
appraisal tools and techniques
22-25

3.5 Perceptual errors of Raters 25-26
Chapter-4(Performance Appraisal System
at GSK,Bangladesh,LTD)
4.1 Aim of Existing Performance Appraisal
System at GSK, Bangladesh, Limited
27
4.2 Uses of Performance Appraisal System at
GSK
27-32
4.3 Performance Appraisal System 28-32
4.4 Evaluation Period 32
4.5 HR Actions 32
4.6 Strengths and Weakness of Performance
Appraisal of GSK
33-34
Chapter-5( Findings and Analysis)
5.1 Analysis and Interpretation of Collected
Data from Respondents
35-40
5.2 Summary of Major findings 40-41
Chapter-6( Conclusion &
Recommendation-Implementation Plan)
6.1 conclusion 42
43-44
6.2 Recommendation and Implementation plan
References 45
Appendix – A 46-49
Appendix – B 50-51

Chapter-1
Introduction

1.1 Introduction
The pharmaceutical industry in Bangladesh is one of the most developed hi-tech sectors within the country's
economy. After the promulgation of Drug Control Ordinance in 1982, the local pharmaceuticals companies
of our country get rapid support for growth and development of this sector was accelerated however, from
then MNC’s are lag behind. There are now about 231 companies in this sector and the approximate total
market size is about Taka 76,500 million per year. Bangladesh Pharmaceutical Industry is now heading
towards self-sufficiency in meeting the local demand. The industry is the second highest contributor to the
national exchequer after garments, and it is the largest white-collar intensive employment sector of the
country.
There are about 450 generics registered in Bangladesh. Out of these 450 generics, 117 are in the controlled
category i.e. in the essential drug list. The remaining 333 generics are in the decontrolled category, the total
number of brands /items that are registered in Bangladesh is currently estimated to be 5,300, while the total
number of dosage forms and strengths are 8,300. Bangladesh pharmaceutical industry is mainly dominated
by domestic manufacturers. Of the total pharmaceutical market of Bangladesh, the local companies are
enjoying a market share reaching around 80%, while the MNCs are having a market share of 20%. The
growth of the country’s domestic pharmaceutical market to the tune of $1.13 billion in terms of value, as it
stands now, is quite a positive development. Such a development has occurred because of decreasing
dependence on imported drugs. Currently about 97% of the total requirement of medicines is created by the
local companies and the rest 3% is imported. The imported drugs mainly comprise of the cancer drugs,
vaccines for viral diseases, hormones etc. Its value-wise growth, recorded at 23.59% in 2011 over that of
2010 points to the fact that many of the pharmaceutical companies have not only successfully replaced the
imported medicines in quality and quantity, but also reached a point where they could be able to capture
markets abroad if only the policy regime is favorable enough.
The top 12 leading pharmaceuticals company in Bangladesh including local and MNC’s are - Square, GSK
Pharma, Beximco, Opsonin Pharma, Eskayef, Renata, A.C.I., Aristopharma, Drug International,
Sanofi Aventis, GSK. Market share of those top pharmaceutical companies’ are shown on a chart below-